Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Buckley

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 29, 2022
International Medical Graduates in the United States Psychiatry WorkforceRobbert J Duvivier, Peter F Buckley, Andrés Martin, et al.
Psychiatry Research|January 8, 2015
How connected are people with schizophrenia? Cell phone, computer, email, and social media useBrian J Miller, Adriana Stewart, John Schrimsher, et al.
The Journal of Clinical Psychiatry|March 2, 2016
An open-label, pilot trial of adjunctive tocilizumab in schizophreniaBrian J Miller, James K Dias, Henrique P Lemos, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 1, 2016
Electronic cigarette use in patients with schizophrenia: Prevalence and attitudesBrian J Miller, Alexandre Wang, Joyce Wong, et al.
Schizophrenia Bulletin|November 18, 2008
Psychiatric comorbidities and schizophreniaPeter F Buckley, Brian J Miller, Douglas S Lehrer, et al.
Psychiatry Research|February 15, 2015
Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysisAnthony O Ahmed, Andrew M Mantini, Daniel J Fridberg, et al.
The Journal of Clinical Psychiatry|August 3, 2010
A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophreniaJohn M Kane, Steven G Potkin, David G Daniel, et al.
The Journal of Clinical Psychiatry|February 8, 2007
The art and science of switching antipsychotic medications, part 2Peter J Weiden, Alexander L Miller, Tim J Lambert, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 31, 2022
The Future of Endowed Chairs in Academic MedicinePeter F Buckley, Patricia J Sime, Love Collins, et al.
Schizophrenia Research|June 21, 2005
Clinicians' recognition of the metabolic adverse effects of antipsychotic medicationsPeter F Buckley, Del D Miller, Beth Singer, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|April 29, 2022
International Medical Graduates in the United States Psychiatry WorkforceRobbert J Duvivier, Peter F Buckley, Andrés Martin, et al.
Psychiatry Research|January 8, 2015
How connected are people with schizophrenia? Cell phone, computer, email, and social media useBrian J Miller, Adriana Stewart, John Schrimsher, et al.
The Journal of Clinical Psychiatry|March 2, 2016
An open-label, pilot trial of adjunctive tocilizumab in schizophreniaBrian J Miller, James K Dias, Henrique P Lemos, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|December 1, 2016
Electronic cigarette use in patients with schizophrenia: Prevalence and attitudesBrian J Miller, Alexandre Wang, Joyce Wong, et al.
Schizophrenia Bulletin|November 18, 2008
Psychiatric comorbidities and schizophreniaPeter F Buckley, Brian J Miller, Douglas S Lehrer, et al.
Psychiatry Research|February 15, 2015
Brain-derived neurotrophic factor (BDNF) and neurocognitive deficits in people with schizophrenia: a meta-analysisAnthony O Ahmed, Andrew M Mantini, Daniel J Fridberg, et al.
The Journal of Clinical Psychiatry|August 3, 2010
A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophreniaJohn M Kane, Steven G Potkin, David G Daniel, et al.
The Journal of Clinical Psychiatry|February 8, 2007
The art and science of switching antipsychotic medications, part 2Peter J Weiden, Alexander L Miller, Tim J Lambert, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 31, 2022
The Future of Endowed Chairs in Academic MedicinePeter F Buckley, Patricia J Sime, Love Collins, et al.
Schizophrenia Research|June 21, 2005
Clinicians' recognition of the metabolic adverse effects of antipsychotic medicationsPeter F Buckley, Del D Miller, Beth Singer, et al.
Pageof 18